|
This is an archive page. The links are no longer being updated.
Calendar Year 2000 Congressional Testimonies
December 5, 2000 - - Jonca Bull, Deputy
Director, Office of Drug Evaluation, Center for Drug Evaluation
and Research, (FDA)
October 5, 2000 - - Drue Barrett, Chief,
Health Activity Working Group, National Center for Environmental
Health (CDC)
October 5, 2000 - - David Satcher, Surgeon
General and Assistant Secretary for Health
October 3, 2000 - - Olivia Golden, Assistant
Secretary, (ACF)
October 3, 2000 - - Jane Henney, Commissioner,
(FDA)
September 28, 2000 - - Greg Koski, Director,
Office of Human Research Protections
September 26, 2000 - - Joseph
Levitt, Director (FDA)
September
25, 2000 - - Joseph Levitt, Director (FDA)
September 21, 2000 - - Kevin Yeskey,
MD
September 21, 2000 - - Bernard S. Arons,
M.D.
September 20, 2000 - - Stephen M.
Ostroff, M.D.
September 20, 2000 - - Jane E. Henney,
M.D.
Subject: Antimicrobial
Resistance and FDA
Before: Senate Committee on Appropriations,
Subcommittee on Labor, Health and Human Services, Education,
and Related Agencies
September 20, 2000 - - Jeffrey P. Koplan,
M.D., M.P.H.
Subject: Antimicrobial
Resistance and FDA
Before: Before: Senate Committee on Appropriations,
Subcommittee on Labor, Health and Human Services, Education,
and Related Agencies
September 20, 2000 - - Statement for
the Record
September 19, 2000 - - William Raub,
Ph.D
September 13, 2000 -- Statement for the Record
September 7, 2000 - - Gerald D. Fischbach,
M.D. (NIH)
Subject: Stem
Cell Research
Before: Senate Appropriations Subcommittee on Labor, HHS,
Education and Related Agencies
September 7, 2000 - - Robert A. Berenson,
M.D. (HCFA)
Subject:
Telemedicine
Before: House Commerce Subcommittee on Health and Environment
September 6, 2000 - - Timothy Westmoreland
(HCFA)
September 5, 2000 - - Steven Pelovitz
(HCFA)
August 9, 2000 - - Allen M. Spiegel,
M.D. (NIH)
Subject: Diabetes
Before: Field Hearing before the Congressional Hispanic
Caucus at
St. Phillip's College in San Antonio, Texas
July
27, 2000 -- Nancy-Ann DeParle (HCFA)
July
26, 2000 -- Ruth L. Kirschstein, M.D. (NIH)
Subject: Health
Disparites, Bridging the Gap
Before: Senate Subcommittee on Public Health; Committee
on Health, Education, Labor and Pensions
July 26, 2000 -- John Callahan (HHS)
Subject: S.
2526, Health Care Improvement Act Reauthorization Bill
Before: Senate Committee on Indian Affairs
July 25, 2000 -- Robert
A. Berenson, M.D.
(HCFA)
Subject: Balanced
Budget Act of 1997
Before: House
Ways and Means Health Subcommittee
July
25, 2000 -- Penny Thompson (HCFA)
Subject: Preventing
Medicaid Fraud
Before: House Government Reform Subcommitee
on Government Management, Information, & Technology
July 20, 2000 - - Francis S. Collins,
M.D., Ph.D. (NIH)
July 18, 2000 -- William Egan,
Ph.D. (FDA)
Subject: Mercury
in Medicine
Before: House Committee on Government Reform
July
18, 2000 -- Marie M. Bristol-Power, Ph.D. (NIH)
Subject: Mercury
in Medicine
Before: House Committee on Government Reform
July 13, 2000 -- Don Lollar, Ed. D. (CDC)
Subject: Improved
Programs for Persons with Disabilities
Before: House Subcommittee on Social Securty of the Ways
and Means Committee
July 13, 2000 -- Rachael Weinstein, R.N. (HCFA)
Subject: Ergonomics
and Health Care Providers
Before: Senate Committe on Health, Education, Labor, and
Pensions; Subcommittee on Employment, Safety, and Training
July 13, 2000 -- Kathryn C. Zoon, Ph.D. (FDA)
Subject: Anthrax
Vaccine
Before: House Committee on Armed Services; Subcommittee
on Military Personnel
July
12, 2000 -- Kathryn C. Zoon, Ph.D. (FDA)
Subject: Anthrax
Vaccine
Before: Senate Committee on Armed Services
July
12, 2000 -- Penny Thompson (HCFA)
Subject:
Medicare and Medicaid
Fraud
Before: House
Budget Committee Health Care Task Force
July 11, 2000 -- Dr. Claude Earl Fox, M.D. , M.P.H.
(HRSA)
Subject: H.R.
4807 - The Ryan White Care Act Amendments
Before: House Commerce Subcommittee on Health and Environment
July 11, 2000 -- Gary Christoph, Ph.D.
(HCFA)
Subject: The
Health Care Infrastructure Improvement Act of 2000
Before: House Committee on Government Reform,
Subcommittee on Government Management, Information and Technology
July 11, 2000 -- Robert Berenson, M.D.
(HCFA)
Subject:
Balanced Budget Act
and Rural Hospitals
Before:
Senate Appropriations Subcommittee on Agriculture, Rural
Development and Related Agencies
June 29, 2000 -- David Satcher, M.D., Ph.D.
(OPHS)
Subject:
Infectious Diseases
Before: House
Committee on International Relations
June 27, 2000 -- David W. Feigal, M.D.
(FDA)
Subject: Re-use
of Medical Devices
Before:
Senate Health, Education, Labor and Pensions Committee
June 27, 2000 -- Michael Hash (HCFA)
Subject: Medicare
Regulations
Before: House
Commerce Subcommittee on Health and Environment
June 26, 2000 -- Jeffrey Kang, M.D. (HCFA)
Subject: Medicare
End Stage Renal Disease Program
Before: Senate Special Committee on Aging
June 22, 2000 -- Linda Rosenstock, M.D., M.P.H. (CDC)
Subject: Needlestick
Injuries
Before: House Subsommittee on Workforce Protections, Committee
on Education and the Workforce
June 15, 2000 -- Linda A. Suydam, D.P.A. (FDA)
Subject: Vaccine
Advisory Committees
Before: House Committee on Government Reform
June 15, 2000 -- Dixie E. Snider, M.D., M.P.H. (CDC)
Subject: Vaccine
Advisory Committees
Before: House Committee on Government Reform
June 14, 2000 -- Nancy-Ann DeParle (HCFA)
Subject: Medicare
Prescription Drug Benefit
Before: House Committee on Commerce, Subcommittee
on Health
and Environment
June 14, 2000 -- Kathy Buto, (HCFA)
Subject: Medicare
in Rural Areas
Before: House Committee on Small Business
June 14, 2000 -- Robert Berenson, M.D. (HCFA)
Subject: Regulatory
Burden on Health Care Providers
Before: House Budget Committee: Health Care Task Force
June 13, 2000 -- Nancy-Ann Deparle (HCFA)
Subject: Medicare
Prescription Drug Benefit
Before: House Ways and Means Committee
June 8, 2000 -- Dennis E. Baker, Associate Commissioner (FDA)
Subject: Counterfeit
Bulk Drugs
Before: House Commerce Subcommittee on Oversight and Investigations
June 7, 2000 --
Jeffrey Kang, MD (HCFA)
Subject: Integrative
Oncology-Cancer Care for the New Millennium
Before: House
Committee on Government Reform
June 7, 2000 -- Richard Pazdur, M.D. (FDA)
Subject: Integrative
Oncology-Cancer Care for the New Millennium
Before: House Committee on Government Reform
May 25, 2000 -- William K. Hubbard, Senior Associate (FDA)
Subject: Enforcing
the Laws of Pharmaceutical Sales over the Interet
Before: House Subcommittee on Oversight and Investigation,
Committee on Commerce
May 25, 2000 -- William F. Raub, Ph.D. (HHS)
Subject: Human
Subject Research Protection
Before: Senate Subcommittee on Public Health; Committee
on Health, Education, Labor, and Pensions
May 18, 2000 -- John Strandberg, D.V.M., Ph.D.
(NCRR)
Subject: Biomedical
Research and Chimpanzees
Before: House Committee on Ways and Means, Subcommittee
on Health
May 16, 2000 -- Steven E. Hyman, M.D. (NIMH)
Subject: Methylphenidate
(Ritalin) for Children with ADHD
Before: House
Education and the Workforce Subcommittee
on Early Childhood, Youth, and Families
May 16, 2000 -- Cindy Mann (HCFA)
Subject: Health
Coverage for Families Leaving Welfare
Before: House Ways & Means Subcommittee on Human Resources
May 16, 2000 -- Michael H. Trujillo, MD, M.P.H., M.S.
(IHS)
Subject: Tribal
Contact Support Cost Technical Amendments of 2000
Before: House Committee on Resources
May
11, 2000 -- David Satcher, M.D., Ph.D. (OPHS)
Subject: The
Health Care Fairness Act of 1999
Before: House Commerce Committee, Subcommittee on Health
and Environment
May 4, 2000 -- Nancy-Ann DeParle (HCFA)
Subject: Medicare
Governance
Before: Senate Committee on Finance
May 3, 2000 -- William F. Raub, Ph.D. (HHS)
Subject: Human
Subject Research Protection
Before: House Committee on Government Reform, Subcommittee
on Criminal Justice
May 2, 2000 -- Kenneth Olden, Ph.D. (NIH)
Subject: Protecting
Our Children from Adverse Environmental Effects
Before: House Appropriations Committee, Subcommittee on
Labor,
Health and Human Services and Education
May 2, 2000 -- Duane Alexander, M.D. (NIH)
Subject: Oversight
Hearing on Children's Environmental Health
Before: House Appropriations Committee, Subcommittee on
Labor,
HHS, and Education
May 2, 2000 -- Richard J. Jackson, M.D., M.P.H. (CDC)
Subject: Children's
Health and the Environment
Before: House Appropriations Committee, Subcommittee on
Labor,
Health and Human Services, and Education
April 26, 2000 -- Allen M. Spiegel, M.D. (NIH)
Subject: The
Promise of Human Pluripotent Stem Cell Research
Before: Senate Committee on Appropriations, Subcommittee
on Labor,
Health and Human Services, Education and Related Agencies
April 13, 2000 -- Food and Drug Administration
Subject: Statement
for the Record on Vaccine Licensing and the Anthrax Vaccine
Before: Senate Committee on Armed Services
April 13, 2000 -- Food and Drug Administration
Subject: Statement
for the Record on Section 4 (Betel Nuts) of H.R. 2462 the
Guam Omnibus Opportunities Act
Before: House Committee on Resources
April 13, 2000 -- Duane Alexander, M.D. (NIH)
Subject: Final
Report of the National Reading Panel
Before: Senate Committe on Appropriations, Subcommittee
on Labor,
Health and Human Services, and Education
April 10, 2000 -- Dorothy Burk Collins (HCFA)
Subject: Medicare
Reimbursement
Before: House Government Reform Subcommittee on Criminal
Justice, Drug Policy, and Human Resources in Fort Wayne,
Indiana
April 6, 2000 -- Coleen Boyle, Ph.D. (CDC)
Subject: Prevention
of Developmental Disabilities
Before: House Committee on Government Reform
April 6, 2000 -- Deborah G. Hirtz, M.D. (NIH)
Subject: The
Challenges of Autism û Why the Increased Rates?
Before: House Committee on Government Reform
April 6, 2000 -- Penny Thompson (HCFA)
Subject: Third
Party Billing
Before: House Committee on Commerce, Subcommittee on Oversight
and Investigations
April 5, 2000 -- Tim Westmoreland (HCFA)
Subject: Medicaid
Payments for School-Based Services
Before: Senate Committee on on Finance
March 29, 2000 -- Michael Hash (HCFA)
Subject: Medicare
Prescription Drug Benefit
Before: Senate Committee on Finance
March 23, 2000 -- Claude Earl Fox, M.D., M.P.H. (HRSA)
Subject: The
Role of Our Safety Net Providers and the Uninsured
Before: Senate Committee on Health, Education, Labor,
and Pensions, Subcommittee on Public Health
March 23, 2000 -- Michael Hash (HCFA)
Subject: Medicare
Coverage of Self-Administered Drugs
Before: House Committee on Commerce, Subcommittee on Health
and the Environment
March 21, 2000 -- Jane E. Henney, M.D. (FDA)
Subject: Hearing
on E-Drugs
Before: Senate Committee on Health, Education, Labor and
Pensions
March 16, 2000 -- Thomas Croft (HRSA)
Subject: National
Practitioner Data Bank
Before: House Committee on Commerce, Subcommittee
on Oversight and Investigations
March 15, 2000 -- Ronald Coene (FDA)
Subject: Agent
Orange: Status of the Air Force Ranch Hand Study
Before: House Committee on Government Reform,
Subcommittee on National Security, Veterans' Affairs,
and International Relations
March 15, 2000 -- Michael Hash (HCFA)
Subject: Fiscal
1999 Chief Financial Officers' Audit
Before: House Government Reform Subcommittee on Government
Management, Information & Technology
March 14, 2000 -- Alan I. Leshner, Ph.D. (NIH)
Subject: Oversight
Hearing on Programs of the Substance
Abuse and Mental Health Services Administration (SAMHSA)
and SAMHSA Coordination with the National Institute on Drug
Abuse
Before: House Committee on Government Reform, Subcommittee
on Criminal Justice, Drug Policy, and Human Resources
March 14, 2000 -- Nelba Chavez, Ph.D. (SAMHSA)
Subject: HHS
Drug Treatment Support
Before: House Committee on Government Reform, Subcommittee
on Criminal Justice, Drug Policy, and Human Resources
March 9, 2000 -- Nancy-Ann DeParle (HCFA)
Subject: The
Fiscal 1999 Chief Financial Officers' Audit
Before: Senate Committtee on Appropriations, Subcommittee
on Labor, Health and Human Services, Education
March 8, 2000 -- Robert F. Knouss, M.D. (OPHS)
Subject: Combating
Terrorism: Management of Medical Stockpiles
Before: House Committee on Government Reform, Subcommittee
on National Security, Veterans' Affairs, and International
Relations
March 8, 2000 -- Michael H. Trujillo, M.D., M.P.H.,
M.S. (IHS)
Subject: The
Indian Health Care Improvement Act
Before: Senate Committee on Indian Affairs
March 8, 2000 -- Claude Earl Fox, M.D., M.P.H. (HRSA)
Subject: National
Rural Development Partnership
Before: Senate Committee on Agriculture, Nutrition and
Forestry, Subcommittee on Forestry, Conservation
and Rural Revitalization
March 8, 2000 -- Stephen M. Ostroff, M.D. (CDC)
Subject: Combating
Terrorism: Management of Medical Stockpiles
Before: House Committee on Government Reform, Subcommittee
on National Security, Veterans' Affairs, and International
Relations
March 6, 2000 -- Michael Mcmullan (HCFA)
Subject: Medicare
Colon Cancer Prevention Efforts
Before: Senate Special Committee on Aging
February 29, 2000 -- The Honorable Donna E. Shalala (HHS)
Subject: President's
FY 2001 Budget for the Department of Health
and Human Services
Before: Senate Committee on Appropriations, Subcommittee
on Labor, Health and Human Services, Education
February 17, 2000 -- Margaret A. Hamburg, M.D. (HHS)
Subject: Confidentiality
of Patient Records
Before: House Committee on Ways and Means, Subcommittee
on Health
February 17, 2000 -- Olivia A. Golden (ACF)
Subject: The
Final Rule on Federal Monitoring of State Child Welfare
Programs
Before: House Committee on Ways and Means, Subcommittee
on
Human Resources
February 17, 2000 -- Camille Barry, Ph.D., R.N. (SAMHSA)
Subject: SAMHSA
Oversight Hearing
Before: House Committee on Government Reform, Subcommittee
on Criminal Justice, Drug Policy, and Human Resources
February 16, 2000 -- Henry Falk, M.D. (ATSDR)
Subject: Asbestos
Exposure
Before: Senate Committee on Environment and Public Works
Field Hearing in Libby, Montana
February 16, 2000 -- Bonnie Washington (HCFA)
Subject: Prescription
Drug Coverage for Medicare Beneficiaries
Before: House Committee on Commerce, Subcommittee on Health
and the Environment
February 14, 2000 -- Helene Gayle, M.D., M.P.H. (CDC)
Subject: HIV
Prevention
Field Hearing in San Francisco, California
February 10, 2000 -- David W. Feigal, M.D. (FDA)
Subject: Medical
Devices
Before: House Committee on Commerce, Subcommittee on Oversight
and Investigations
February 8, 2000 -- The Honorable Donna E. Shalala (HHS)
Subject: President's
FY 2001 Budget for the Department of Health
and Human Services.
Before: House Committee on Appropriations, Subcommittee
on
Labor, Health and Human Services, and Education
February 8, 2000 -- Steven E. Hyman, M.D. (NIH)
Subject: Suicide
Awareness and Prevention
Before: Senate Committee on Appropriations, Subcommittee
on Labor, Health and Human Services, Education
February 8, 2000 -- David Satcher, M.D., Ph.D. (OPHS)
Subject: Suicide
Awareness and Prevention
Before: Senate Committee on Appropriations, Subcommittee
on Labor, Health and Human Services, Education
February 2, 2000 -- Amy Patterson, M.D. (NIH)
Subject: Gene
Therapy: Is There Oversight for Patient Safety?
Before: Senate Committee on Health, Education, Labor and
Pensions, Subcommittee on Public Health
February 2, 2000 -- Jay P. Siegel, M.D. (FDA)
Subject: Gene
Therapy: Is There Oversight for Patient Safety?
Before: Senate Committee on Health, Education, Labor and
Pensions, Subcommittee on Public Health
February 2, 2000 -- Drue H. Barrett, Ph.D. (CDC)
Subject: Gulf
War Veterans' Illnesses
Before: House Committee on Government Reform, Subcommittee
on National Security, Veterans' Affairs and International
Relations
February 1, 2000 -- Janet Woodcock (FDA)
Subject: Medical
Errors: Understanding Adverse Drug Events
Before: Senate Committee on Health, Education, Labor, and
Pensions
HHS Home |
ASL Home
Disclaimers |
Privacy Notice |
FOIA |
Accessibility |
Contact Us
Last revised: January 22, 2004
|